
Roche Holding AG
RHHVF | OTC
$447.20
+$3.90 (+0.88%)
Sep 22, 2026, 10:18 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 31.85B | 31.64B | 30.76B | 29.83B | 29.78B | 30.99B | 32.3B | 32.09B | 30.71B | 29.04B | 29.28B |
Cost of Revenue | 7.75B | 8.81B | 7.47B | 8.28B | 7.54B | 9.09B | 9.75B | 10.47B | 9.24B | 8.45B | 7.91B |
Gross Profit | 24.1B | 22.83B | 23.28B | 20.66B | 22.24B | 21.9B | 22.55B | 21.62B | 21.47B | 20.59B | 21.37B |
Operating Income | 10.33B | 4.35B | 9.07B | 5.63B | 9.46B | 7.9B | 10.27B | 8.05B | 9.23B | 7.88B | 9.84B |
Interest Income | n/a | 260M | n/a | 25.5M | 169.5M | 157M | 127M | 87M | 84M | 103.5M | 107.5M |
Pretax Income | 9.59B | 3.57B | 8.22B | 4.92B | 9.19B | 5.37B | 11B | 7.51B | 9.89B | 7.79B | 10.18B |
Net Income | 7.41B | 2.02B | 6.26B | 4.36B | 7.14B | 3.89B | 8.53B | 6.13B | 7.8B | 6.22B | 8.08B |
Selling & General & Admin | 6.59B | 8.44B | 6.46B | 6.89B | 6.4B | 6.46B | 5.57B | 6.42B | 5.46B | 6.2B | 5.63B |
Research & Development | 6.68B | 7.92B | 7.39B | 6.94B | 6.29B | 7.42B | 6.63B | 7.02B | 6.69B | 6.37B | 5.79B |
Other Expenses | 508M | 2.13B | 369M | -62M | n/a | n/a | n/a | -136M | n/a | -144M | -121M |
Operating Expenses | 13.77B | 18.48B | 14.21B | 13.77B | 12.78B | 14B | 12.27B | 13.57B | 12.25B | 12.71B | 11.53B |
Interest Expense | n/a | 1.4B | n/a | 592M | 405M | 350M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 2.55B | n/a | 2.59B | 2.15B | 2.43B | 2.27B |
Cost & Expenses | 21.52B | 27.29B | 21.69B | 24.19B | 20.32B | 23.08B | 22.02B | 24.03B | 21.49B | 21.16B | 19.44B |
Income Tax Expense | 1.76B | 1.08B | 1.53B | 110M | 1.61B | 972M | 1.82B | 792M | 1.67B | 1.18B | 1.72B |
Shares Outstanding (Basic) | 802.82M | 802.31M | 802.31M | 797.24M | 799M | 799.18M | 809.3M | 844.96M | 854M | 855M | 855M |
Shares Outstanding (Diluted) | 803M | 802M | 802M | 804M | 804M | 799.18M | 810M | 857.47M | 862M | 863.7M | 866M |
EPS (Basic) | 9.31 | 2.52 | 7.80 | 5.47 | 8.93 | 4.87 | 10.54 | 7.25 | 9.14 | 7.27 | 9.45 |
EPS (Diluted) | 9.23 | 2.52 | 7.80 | 5.42 | 8.88 | 4.87 | 10.53 | 7.15 | 9.05 | 7.20 | 9.33 |
EBITDA | 13.05B | 10.38B | 12.34B | 8.7B | 11.21B | 9.82B | 12.18B | 10.23B | 11.5B | 10.25B | 12.04B |
EBIT | 11.51B | 3.72B | 9.47B | 7.15B | 5.45B | 1.99B | 10.27B | 8.05B | 9.23B | 7.88B | 9.84B |
Depreciation & Amortization | 1.54B | 1.61B | 1.49B | 1.55B | 1.75B | 1.92B | 1.9B | 2.18B | 2.27B | 2.37B | 2.2B |
Add to Watchlist
Select watchlists to add or remove RHHVF